Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Bauser

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Chromatographic Science|June 7, 2002
Preparative high-performance liquid chromatography-mass spectrometry for the high-throughput purification of combinatorial librariesMarcus Bauser
Angewandte Chemie (International Ed. in English)|May 2, 2018
Investigation of the Molecular Recognition of Amino Acids by Cyclopeptides with Reflectometric Interference SpectroscopyDietmar Leipert, Dirk Nopper, Marcus Bauser, et al.
Chemmedchem|August 24, 2016
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876Holger Siebeneicher, Arwed Cleve, Hartmut Rehwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2016
Identification of novel GLUT inhibitorsHolger Siebeneicher, Marcus Bauser, Bernd Buchmann, et al.
Investigative Radiology|June 15, 2022
Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast AgentJessica Lohrke, Markus Berger, Thomas Frenzel, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179Jeffrey Mowat, Alexander H M Ehrmann, Sven Christian, et al.
Inorganic Chemistry|April 22, 2017
Hafnium-Based Contrast Agents for X-ray Computed TomographyMarkus Berger, Marcus Bauser, Thomas Frenzel, et al.
Investigative Radiology|June 15, 2016
Characterization of a Novel Hafnium-Based X-ray Contrast AgentThomas Frenzel, Marcus Bauser, Markus Berger, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activityDieter Beyer, Hein-Peter Kroll, Rainer Endermann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
<sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of ThrombiJessica Lohrke, Holger Siebeneicher, Markus Berger, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Chromatographic Science|June 7, 2002
Preparative high-performance liquid chromatography-mass spectrometry for the high-throughput purification of combinatorial librariesMarcus Bauser
Angewandte Chemie (International Ed. in English)|May 2, 2018
Investigation of the Molecular Recognition of Amino Acids by Cyclopeptides with Reflectometric Interference SpectroscopyDietmar Leipert, Dirk Nopper, Marcus Bauser, et al.
Chemmedchem|August 24, 2016
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876Holger Siebeneicher, Arwed Cleve, Hartmut Rehwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|March 8, 2016
Identification of novel GLUT inhibitorsHolger Siebeneicher, Marcus Bauser, Bernd Buchmann, et al.
Investigative Radiology|June 15, 2022
Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast AgentJessica Lohrke, Markus Berger, Thomas Frenzel, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179Jeffrey Mowat, Alexander H M Ehrmann, Sven Christian, et al.
Inorganic Chemistry|April 22, 2017
Hafnium-Based Contrast Agents for X-ray Computed TomographyMarkus Berger, Marcus Bauser, Thomas Frenzel, et al.
Investigative Radiology|June 15, 2016
Characterization of a Novel Hafnium-Based X-ray Contrast AgentThomas Frenzel, Marcus Bauser, Markus Berger, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activityDieter Beyer, Hein-Peter Kroll, Rainer Endermann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
<sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of ThrombiJessica Lohrke, Holger Siebeneicher, Markus Berger, et al.
Pageof 3